Doxofylline SR & Montelukast Tablets Exporter India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Doxofylline SR & Montelukast tablets are a combination respiratory formulation designed to provide dual benefits of bronchodilation and anti-allergic action. Doxofylline (sustained-release) helps relax bronchial smooth muscles for improved airflow, while Montelukast works as a leukotriene receptor antagonist to reduce inflammation and allergic responses in the airways.

Doxofylline SR Montelukast tablets exporter India and bronchodilator anti allergic combination supplier India are highly searched by respiratory medicine importers and distributors. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India respiratory combination medicines partner, delivering advanced formulations for global supply chains.

Combination of bronchodilator (Doxofylline) and anti-allergic (Montelukast) for dual respiratory action
Sustained-release formulation for prolonged therapeutic effect
Provides effective bronchodilation with improved safety profile
Helps reduce airway inflammation and bronchospasm
Ensures consistent plasma drug levels for better symptom control
Manufactured under cGMP and ISO-certified standards
Suitable for chronic respiratory disease management

Management of bronchial asthma
Treatment of chronic obstructive pulmonary disease (COPD)
Relief from allergic respiratory conditions
Prevention of exercise-induced bronchospasm
Support in allergic rhinitis with airway involvement
Improves breathing, lung function, and overall respiratory health

Extended drug release for long-lasting effect
Reduced dosing frequency improves patient compliance
Minimizes peak-related side effects
Provides stable and controlled drug delivery
Accurate dosing with high stability and shelf life
Ideal for chronic therapy and long-term disease management